Project Grant DP2GM150018
- This $1,344,223 Project Grant awarded by the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), is funding research to develop a novel nanomaterial-based platform for noninvasive neuroengineering. The key objectives are to: Engineer ultra-bright upconversion nanoparticles that can convert near-infrared light into visible light for deep brain optogenetic stimulation. Leverage focused ultrasound to deliver the nanoparticles across the...
- The National Institutes of Health National Institute of Neurological Disorders and Stroke awarded $3.6 million under the 21st Century Cures Act Brain Research through Advancing Innovative Neurotechnologies program (CFDA 93.372) to Stanford University. The project grant will support development of a noninvasive, dynamically programmable in vivo light source for rapid brain-wide optogenetic screening. Specifically, the awardee aims to develop mechanoluminescent nanoparticles with distinct emission...
- This $1,417,500 Project Grant awarded by the National Institutes of Health (NIH) under the Trans-NIH Research Support program (CFDA 93.310) funds the development of "Electrified Cryo-EM", a novel tool that can kinetically trap biological systems in their metastable, non-equilibrium states. The research aims to unravel the structural changes in neurons during an action potential across multiple length scales, from voltage-gated channel proteins to the synaptic junction. Specifically,...
- This Project Grant award of $348,373 from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), aims to develop a novel family of biosensors that can be used to report on and dynamically regulate changes in neuroinflammation within the brains of live animals. The key products and services to be delivered through this grant include: 1) Developing and...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $388,158.00 to the University of California, Los Angeles (UCLA) to engineer a highly active and selective gamma-Aminobutyric Acid (GABA) oxidase enzyme. The goal is to develop a high-performance, implantable, electroenzymatic GABA microsensor that can monitor GABA transients in the...
- This NSF Engineering Program award of $605,320 to North Carolina State University (NC State) supports the development of a flexible, FMRI-compatible neural probe with multi-modal sensing and modulation capabilities. The novel probe is designed to advance understanding of neural circuit dynamics and enable closed-loop neuromodulation for treating neurological disorders. Key product elements include: Flexible, multi-shank neural probe fabricated using polymeric materials to enable deep brain...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $434,610 to the Florida Institute of Technology Inc. (Florida TECH) for the development of light-triggered molecular tools to manipulate neuronal connections and study brain function. The principal investigator, Dr. Nasri Nesnas, will collaborate with neuroscientists, including Dr. Attila Losonczy from Columbia University, to design and utilize these...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), will fund the development and validation of a family of genetically encoded, fluorescent "chemogenetic" voltage sensors for in vivo brain imaging. The 3-year, $2,329,605 grant to Brown University aims to create improved far-red and two-photon compatible...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $659,217 to develop a novel microelectrode sensor to continuously measure endogenous neuropeptide Y (NPY) release in brain tissue and single cells. The primary objective is to enhance detection of NPY, a key neuropeptide implicated in neurological disorders, by optimizing an existing NPY biosensor to improve sensitivity and selectivity while...
- This Project Grant award from the National Science Foundation's (NSF) Engineering program (CFDA 47.041) provides $540,458 to Louisiana Tech University to develop an advanced implantable neural interface device. The device is designed to simultaneously monitor multiple types of brain signals, including both chemical (neurotransmitter) and electrical (electrophysiological) activity, over extended periods in vivo. By integrating advanced materials with innovative fabrication techniques, the project...
BUILDING A TWO-WAY COMMUNICATION SYSTEM: BIO-ORTHOGONAL SUPERHYDROPHOBIC NANOPARTICLES FOR CONTROLLED STIMULATION AND REAL-TIME SENSING OF NEUROTRANSMITTERS - PROJECT SUMMARY: TECHNOLOGIES FOR MONITORING CHEMICAL SIGNALING IN NEURONAL ACTIVITIES HAVE LONG BEEN DESIRED TO UNDERSTAND THE MYSTERIOUS FUNCTION OF THE BRAIN, AND THE UNRAVEL UNDERLYING MECHANISMS OF NEUROLOGICAL DISORDERS SUCH AS EPILEPSY AND ALZHEIMER'S DISEASE. THIS PROJECT CREATES NOVEL BIO- ORTHOGONAL NANOSENSORS FOR IN-VITRO AND IN-VIVO IMAGING OF PHYSIOLOGICAL IONS AND SMALL MOLECULE NEUROTRANSMITTERS SUCH AS ACETYLCHOLINE. PHYSIOLOGICAL IONS SUCH AS K+, NA+, CL-, AND CA2+ ARE KEY TO MEMBRANE POTENTIAL OF THE NEURON, AND PROPAGATION OF ACTION POTENTIALS. IN-VITRO AND IN- VIVO RECORDING OF LEVELS OF THESE IONS DURING NEURONAL COMMUNICATION HAS BEEN FOCUS OF RESEARCH FOR DECADES. THE NEUROTRANSMITTER ACETYLCHOLINE (ACH) IS INVOLVED IN MEMORY AND LEARNING WITH IMPLICATIONS IN ALZHEIMER'S DISEASE AND PSYCHIATRIC DISORDERS. STUDYING ACH IS IMPORTANT FOR UNRAVELLING THE PATHOPHYSIOLOGY OF NEURODEGENERATIVE AND UNDERSTUDYING THE CONNECTION BETWEEN THE GUT MICROBIOME AND BRAIN HEALTH. THE SCOPE OF WORK PROPOSED IN THIS APPLICATION HAS POTENTIAL TO CONTRIBUTE MAJOR ADVANCES IN PUBLIC HEALTH THROUGH BETTER UNDERSTANDING OF DISEASE PATHOPHYSIOLOGY. THE IMMEDIATE GOAL OF THIS PROPOSAL TO CREATE BIO-ORTHOGONAL FLUOROUS NANOSENSORS WITH DUAL FUNCTIONALITIES. TO SENSE IONIC NEUROTRANSMITTERS AND TO RELEASE THESE COMPOUNDS UPON LIGHT STIMULATION. THE NANOPARTICLES WILL BE DEVELOPED USING FLUOROUS MATERIALS. FLUOROUS COMPOUNDS (MOLECULES WITH HIGH CONTENT OF FLUORINE ATOMS) ARE EXTREMELY NON-POLAR AND NON-POLARIZABLE TO THE EXTENT THAT THEY ARE NOT MISCIBLE WITH WATER AND FATTY SUBSTANCES. THAT IS, FLUORINATED COMPOUNDS ARE BOTH HYDROPHOBIC AND LIPOPHOBIC. AS A MATTER OF FACT, LIVING SYSTEMS ARE MADE OF WATER AND LIPOPHILIC COMPOUNDS, MAKING FLUOROCARBONS BIO-ORTHOGONAL, MEANING THAT THEY DO NOT INTERFERE WITH BIOLOGY. THIS FEATURE ALLOWS DEVELOPMENT OF STABLE AND NONTOXIC NANOSENSORS WITH WIDESPREAD APPLICATIONS. THE SCIENTIFIC QUESTIONS THAT THIS PROPOSAL IS ANSWERING ARE (I) CAN WE CONTROL THE FLUOROUS- AQUEOUS INTERFACE AND USE PARTIALLY FLUORINATED VOLTAGE SENSITIVE DYES FOR CONTACT-FREE READOUT OF INTERFACIAL POTENTIAL? (II) CAN WE RECORD CHEMICAL SIGNALING IN NEURONAL COMMUNICATION USING A PLATFORM AND MODULAR FLUOROUS NANOSENSOR? (III) CAN WE TRAP FLUORINATED METASTABLE-PHOTO-ACIDS IN SUPERHYDROPHOBIC NANOPARTICLES AND USE BLUE LIGHT FOR LOCAL RELEASE OF IONIC MOIETIES? (IV) CAN WE USE LOCAL RELEASE OF IONS TO START A DIALOGUE WITH NERVE CELLS, AND MIMIC THE CHEMICAL SIGNALING?
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $926.7k | 8/26/25 | ||
| Not listed | $1.3m | 9/15/22 | ||
| Not listed | $1.3m | 9/15/22 |